Menu
Content/Inhalt
Home
|
Careers
|
Contact us
Search
Welcome
At a glance
Social responsibility
Our companies
Business Model
Development capabilites
Partnering
Pipeline
Commercial Products
News & Events
News
27.04.2010
Debiopharm Group™ starts Phase I clinical trial with Debio 0932
26.04.2010
Two New Tenants for EPFL’s Innovation Square
Home
H3 Pharma receives Orphan-drug designation from the FDA for: monoclonal antibody SC-1, in gastric cancer
MONOCLONAL ANTIBODY SC-1, IN GASTRIC CANCER - 12th Nov 2003
SANVAR SR IN ACROMEGALY - 5th Nov 2003